Patient Guide: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04544189
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Neoplasms
Phase: PHASE2

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Hefei, Anhui
  • • Hefei, Anhui
  • • Guangzhou, Guangdong
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer - Join Clinical Trial NCTNCT04544189

How to Join This Clinical Trial - NCTNCT04544189

Learn how to participate in this PHASE2 trial studying an investigational therapy for Breast Neoplasms. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Breast Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Breast Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04544189 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230001 - China

Status: Contact for availability

Clinical Research Site

Hefei, Anhui 230031 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510000 - China

Status: Contact for availability

Clinical Research Site

Shijiazhuang, Hebei 050011 - China

Status: Contact for availability

Clinical Research Site

Harbin, Heilongjiang 150081 - China

Status: Contact for availability

Clinical Research Site

Zhengzhou, Henan 450008 - China

Status: Contact for availability

Clinical Research Site

Wuhan, Hubei 430022 - China

Status: Contact for availability

Clinical Research Site

Changsha, Hunan 410013 - China

Status: Contact for availability

Clinical Research Site

Nanjing, Jiangsu 210009 - China

Status: Contact for availability

Clinical Research Site

Nanjing, Jiangsu 210029 - China

Status: Contact for availability

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Breast Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships